韩国芯片股价在2025年11月24日上,因为美国市场的担忧减轻,而一家新的生物制药公司在首次亮相时升. South Korean chip stocks rose on Nov. 24, 2025, as U.S. market worries eased, while a new biopharm company surged on its debut.

2025年11月24日, 韩国芯片制造商三星电子公司(Samsung Electronics)和SK Hynix(SK Hynix)发现他们的股票在2025年11月24日有所上升, South Korean chipmakers Samsung Electronics and SK hynix saw their stocks rise on November 24, 2025, as U.S. market concerns eased, with Samsung gaining 3.06% and SK hynix up 1.54%, recovering from steep Friday losses. 美国股票表现强劲后反弹,对美联储推迟削减利率的担心也减少,尽管AI泡沫只涉及有限的收益。 The rebound followed stronger U.S. stock performance and reduced fears of a delayed Federal Reserve rate cut, though AI bubble concerns limited gains. 分析家将最近的波动归因于流动性的转移,而不是基本因素,支持对底盘的买进办法。 Analysts attributed recent volatility to liquidity shifts, not fundamentals, supporting a buy-on-dips approach. 与此同时,Samyang Biopharm, 刚从Samyang控股公司抽出, 在首个交易日猛涨29.89%, Meanwhile, Samyang Biopharm, newly spun off from Samyang Holdings, surged 29.89% on its first trading day, hitting the daily limit at 30,200 won after a pure split that gave shareholders stakes in both companies.